These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 1975441)

  • 1. Genetic regulation of acetyltransferases in the Syrian inbred hamster: a model for man.
    Hein DW; Trinidad A; Yerokun T; Kirlin WG; Ogolla F; Ferguson RJ; Andrews AF
    Prog Clin Biol Res; 1990; 340B():115-24. PubMed ID: 1975441
    [No Abstract]   [Full Text] [Related]  

  • 2. Metabolic activation of N-hydroxy-2-aminofluorene and N-hydroxy-2-acetylaminofluorene by monomorphic N-acetyltransferase (NAT1) and polymorphic N-acetyltransferase (NAT2) in colon cytosols of Syrian hamsters congenic at the NAT2 locus.
    Hein DW; Doll MA; Gray K; Rustan TD; Ferguson RJ
    Cancer Res; 1993 Feb; 53(3):509-14. PubMed ID: 8425184
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolic activation of carcinogenic arylamines by rapid acetylator, slow acetylator, and chimeric recombinant Syrian hamster NAT2 allozymes.
    Hein DW; Doll MA; Ferguson RJ
    Proc West Pharmacol Soc; 1995; 38():59-62. PubMed ID: 7480023
    [No Abstract]   [Full Text] [Related]  

  • 4. Dinitropyrene-resistant Salmonella typhimurium are deficient in an acetyl-CoA acetyltransferase.
    Orr JC; Bryant DW; McCalla DR; Quilliam MA
    Chem Biol Interact; 1985; 54(3):281-8. PubMed ID: 2865012
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exposure to, and activation of, the food derived mutagenic heterocyclic amine MeIQx.
    Gooderham NJ; Murray BP; Murray S; Boobis AR; Davies DS
    Prog Clin Biol Res; 1990; 340B():67-76. PubMed ID: 2203021
    [No Abstract]   [Full Text] [Related]  

  • 6. Construction of Syrian hamster lines congenic at the polymorphic acetyltransferase locus (NAT2): acetylator genotype-dependent N- and O-acetylation of arylamine carcinogens.
    Hein DW; Doll MA; Rustan TD; Gray K; Ferguson RJ; Feng Y
    Toxicol Appl Pharmacol; 1994 Jan; 124(1):16-24. PubMed ID: 8291057
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A unique pharmacogenetic expression of the N-acetylation polymorphism in the inbred hamster.
    Hein DW; Omichinski JG; Brewer JA; Weber WW
    J Pharmacol Exp Ther; 1982 Jan; 220(1):8-15. PubMed ID: 7053425
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acetylator genotype-dependent expression of arylamine N-acetyltransferase and N-hydroxyarylamine O-acetyltransferase in Syrian inbred hamster intestine and colon. Identity with the hepatic acetylation polymorphism.
    Ogolla F; Ferguson RJ; Kirlin WG; Trinidad A; Andrews AF; Mpezo M; Hein DW
    Drug Metab Dispos; 1990; 18(5):680-5. PubMed ID: 1981720
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biochemical and genetic analysis of two acetyltransferases from hamster tissues that can metabolize aromatic amine derivatives.
    Land SJ; Jones RF; King CM
    Carcinogenesis; 1994 Aug; 15(8):1585-95. PubMed ID: 8055637
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Syrian hamster monomorphic N-acetyltransferase (NAT1) alleles: amplification, cloning, sequencing, and expression in E. coli.
    Ferguson RJ; Doll MA; Rustan TD; Baumstark BR; Hein DW
    Pharmacogenetics; 1994 Apr; 4(2):82-90. PubMed ID: 8081415
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acetyl-CoA dependent O-acetylation of N-hydroxyarylamines in bacterial and mammalian cells--the significance for mutagenesis and carcinogenesis.
    Kato R; Kamataki T; Saito K; Shinohara A
    Prog Clin Biol Res; 1986; 209A():507-14. PubMed ID: 3529109
    [No Abstract]   [Full Text] [Related]  

  • 12. Effect of Aroclor 1254 dose upon S9 activation of aromatic amine bacterial mutagens.
    Thompson CZ; Whitaker GW; McMahon RE
    Mutat Res; 1980 Apr; 77(4):361-6. PubMed ID: 6769038
    [No Abstract]   [Full Text] [Related]  

  • 13. Purification of hepatic polymorphic arylamine N-acetyltransferase from homozygous rapid acetylator inbred hamster: identity with polymorphic N-hydroxyarylamine-O-acetyltransferase.
    Trinidad A; Hein DW; Rustan TD; Ferguson RJ; Miller LS; Bucher KD; Kirlin WG; Ogolla F; Andrews AF
    Cancer Res; 1990 Dec; 50(24):7942-9. PubMed ID: 2253236
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic regulation of N-acetyltransferase in target organs of arylamine tumors: homologous expression in human and hamster bladder and colon.
    Hein DW
    Proc West Pharmacol Soc; 1991; 34():55-60. PubMed ID: 1788341
    [No Abstract]   [Full Text] [Related]  

  • 15. Acetyltransferase and sulfotransferase which activate mutagens and carcinogens through O-esterification mechanisms.
    Yamazoe Y; Abu-Zeid M; Gong DW; Ozawa S; Nagata K; Kato R
    Princess Takamatsu Symp; 1990; 21():109-17. PubMed ID: 2134670
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolic activation by hamster and rat hepatocytes in the Salmonella mutagenicity assay.
    Poiley JA; Raineri R; Andrews AW; Cavanaugh DM; Pienta RJ
    J Natl Cancer Inst; 1980 Dec; 65(6):1293-8. PubMed ID: 7001125
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inheritance of liver N-acetyltransferase activity in the rapid and slow acetylator inbred hamster.
    Hein DW; Kirlin WG; Ferguson RJ; Weber WW
    J Pharmacol Exp Ther; 1985 Jun; 233(3):584-7. PubMed ID: 3874278
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Extrahepatic expression of N-acetylator genotype in the inbred hamster.
    Hein DW; Kirlin WG; Ogolla F; Trinidad A
    Drug Metab Dispos; 1987; 15(1):68-73. PubMed ID: 2881761
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic control of acetyl coenzyme A-dependent arylamine N-acetyltransferase, hydrazine N-acetyltransferase, and N-hydroxy-arylamine O-acetyltransferase enzymes in C57BL/6J, A/J, AC57F1, and the rapid and slow acetylator A.B6 and B6.A congenic inbred mouse.
    Hein DW; Trinidad A; Yerokun T; Ferguson RJ; Kirlin WG; Weber WW
    Drug Metab Dispos; 1988; 16(3):341-7. PubMed ID: 2900723
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical consequences of acetylation polymorphism].
    Jendryczko A; Gmiński J
    Pol Tyg Lek; 1984 Sep; 39(37):1249-52. PubMed ID: 6150471
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.